Rita Jain
Director/Board Member at CELLDEX THERAPEUTICS, INC.
Net worth: - $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert Michael | M | 53 | 12 years | |
| Sam Martin | M | 53 | 15 years | |
| Eric Loumeau | M | 61 | 6 years | |
| Anthony Marucci | M | 62 | 41 years | |
| Erik van den Berg | M | 51 |
AM-Pharma Holding BV
 AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands.
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | 17 years |
| Karen Shoos | F | 70 | 23 years | |
| Daniel Faga | M | 44 | 3 years | |
| Hubert Allen | M | 58 | 18 years | |
| Sarah Boylan Cavanaugh | F | 49 | 12 years | |
| Herbert Conrad | M | 91 | 16 years | |
| Olivier Bogillot | M | - | 1 years | |
| Oleg Nodelman | M | 47 | 3 years | |
| John Schmid | M | 61 | 9 years | |
| Juliane Bernholz | M | - |
AM-Pharma Holding BV
AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands.
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | 5 years |
| Robert Alpern | M | 73 | 16 years | |
| Mary Moreland | F | 57 | 13 years | |
| Geert-Jan Mulder | M | 58 |
AM-Pharma Holding BV
AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands.
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | - |
| Margo Heath-Chiozzi | M | 67 | 16 years | |
| Keith Brownlie | M | 71 | 7 years | |
| Sally Blount | M | 62 | 13 years | |
| Cynthia Smith | F | 55 | 6 years | |
| Rémi Droller | M | 48 |
AM-Pharma Holding BV
AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands.
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | - |
| J. Ware | M | 71 | 7 years | |
| Harry Penner | M | 78 | 27 years | |
| Debora Pellicano | F | - | 1 years | |
| Hollings Renton | M | 77 | 9 years | |
| Dennis Fenton | M | 72 | 6 years | |
| James Marino | M | 74 | 7 years | |
| Michael Rogers | M | 64 | 6 years | |
| Adrian Adams | M | 73 | 6 years | |
| Garry Neil | M | 70 | 2 years | |
| Nick Montemarano | M | - | - | |
| Nancy McKinstry | F | 65 | 13 years | |
| Cheryl L. Cohen | F | 58 | 2 years | |
| Tibor Keler | M | 65 | 41 years | |
| Steven Gilman | M | 71 | 6 years | |
| Patrick Honoré | M | - |
AM-Pharma Holding BV
AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands.
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | - |
| Ravindra Mehta | M | - |
AM-Pharma Holding BV
AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands.
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | - |
| Magda Marquet | M | 65 | 3 years | |
| David McKeon | M | 52 | 7 years | |
| Felice Verduyn-van Weegen | F | - |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | - |
| Diane Young | M | 68 | 5 years | |
| Priya Raina | F | - | 2 years | |
| Ching Yau Yi | F | - | 2 years | |
| Beth Mueller | F | - | 5 years | |
| Sangita Ghosh | M | - | 4 years | |
| Martin Dahl | M | - | 6 years | |
| Guido Magni | M | 70 |
AM-Pharma Holding BV
AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands. | - |
| Richard Wright | M | 60 | 12 years | |
| Edwin de Graaf | M | - |
AM-Pharma Holding BV
AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands. | - |
| Dennis Mulroy | M | 69 | 4 years | |
| John M. Capek | M | 62 | 18 years | |
| Martijn Kleijwegt | M | 69 |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | - |
| Joël Jean-Mairet | M | 52 |
AM-Pharma Holding BV
AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands. | - |
| Russell Greig | M | 71 |
AM-Pharma Holding BV
AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands. | - |
| Klaus Breiner | M | - |
AM-Pharma Holding BV
AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands. | - |
| Raphaël Wisniewski | M | 54 |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | - |
| Steven Burke | M | 63 | 5 years | |
| Lewis Gryziewicz | M | - | 5 years | |
| Ronald A. Pepin | M | 68 | 13 years | |
| Elizabeth Crowley | F | 52 | 15 years | |
| Steve Connor | M | - |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | 17 years |
| Monique da Silva | F | - | - | |
| Paul Lizzul | M | 49 | 4 years | |
| William L. Macias | M | 66 | 3 years | |
| Andrea van Elsas | M | 58 |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | 13 years |
| Roopal Thakkar | M | - | 21 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Thomas Schall | M | 64 | 25 years | |
| Susan M. Kanaya | F | 61 | 16 years | |
| Ashleigh Palmer | M | 61 | 7 years | |
| Richard Gonzalez | M | 70 | 33 years | |
| Jeffrey Leiden | M | 68 | 6 years | |
| Wayne Pisano | M | 69 | 5 years | |
| David Wheadon | M | 66 | 5 years | |
| James Tyree | M | 71 | 23 years | |
| James Farrell | M | 81 | - | |
| Duane Nash | M | 53 | 5 years | |
| Michael Clayman | M | 72 | 4 years | |
| Geoffrey Parker | M | 59 | 13 years | |
| Sujata Dayal | F | 61 | 5 years | |
| Theresa McNeely | F | 60 | 2 years | |
| Jodie Morrison | F | 48 | 2 years | |
| Jennifer Herron | F | 54 | - | |
| Bill Slattery | M | - | - | |
| Michael Heffernan | M | 59 | 4 years | |
| Thomas A. Edwards | M | 65 | 7 years | |
| Markus J. Cappel | M | 63 | 21 years | |
| Muneer Satter | M | 63 | 5 years | |
| Phebe Novakovic | F | 66 | 11 years | |
| James Topper | M | 62 | 16 years | |
| Terrence Kearney | M | 69 | 25 years | |
| Avery Catlin | M | 75 | 5 years | |
| William Osborn | M | 76 | 15 years | |
| Edward Liddy | M | 78 | 11 years | |
| Samuel Scott | M | 79 | 13 years | |
| Glenn Tilton | M | 75 | 16 years | |
| Henry McKinnell | M | 81 | 6 years | |
| Joseph Feczko | M | 75 | 10 years | |
| Laura Schumacher | F | 60 | 5 years | |
| Sharon Greenlees | F | 52 | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 84 | 84.00% |
| Netherlands | 16 | 16.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Rita Jain
- Personal Network
